IDEXX Laboratories (XTER:IX1) Tariff Resilience Score: 8/10 (As of Jun. 25, 2026)


XTER:IX1 IDEXX Laboratories Inc XTER:IX1
96 GF Score
Price €488.90
GF Value €561.51
View Full Analysis

What is IDEXX Laboratories Tariff Resilience Score?

IDEXX Laboratories XTER:IX1 96 Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus rates XTER:IX1 with a GF Score™ of 96/100 and a GF Value™ of €561.51. Among 216 Medical Diagnostics & Research companies, IDEXX Laboratories ranks better than 98.15% on this metric.

IDEXX Laboratories has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

IDEXX Laboratories has IDEXX Laboratories has a strong global presence in veterinary diagnostics, with diversified manufacturing and sales markets. The company has shown resilience to past tariffs due to its pricing power and ability to shift production. Industry-specific exemptions for medical products further enhance its tariff resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes IDEXX Laboratories might have Highly Resilient.

IDEXX Laboratories  (XTER:IX1) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

IDEXX Laboratories Tariff Resilience Score Related Terms

XTER:IX1 vs A, WAT, NTRA: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDEXX Laboratories Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Tariff Resilience Score falls into.


XTER:IX1
96GF Score
IDEXX Laboratories Inc XTER:IX1
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
IDEXX Laboratories (XTER:IX1) has a Tariff Resilience Score of 8 as of Jun. 25, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, IDEXX Laboratories ranks #4 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 1.9%.
Is IDEXX Laboratories' Tariff Resilience Score too high?
IDEXX Laboratories' current Tariff Resilience Score is 8. Based on the distribution chart, IDEXX Laboratories ranks #4 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, IDEXX Laboratories has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Tariff Resilience Score compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #4 out of 216 companies for Tariff Resilience Score. This places IDEXX Laboratories in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. IDEXX Laboratories's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
IDEXX Laboratories (XTER:IX1) has a current Tariff Resilience Score of 8. The stock's GF Value™ is €561.51, compared to a current price of €488.90 — trading 12.9% below its estimated fair value. The current Tariff Resilience Score is 8. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For IDEXX Laboratories (XTER:IX1), the current Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (XTER:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €488.90 is trading 12.9% below its estimated GF Value™ of €561.51.

Key valuation signals for XTER:IX1:

  • Tariff Resilience Score: 8
  • GF Value™: €561.51 vs. price of €488.90 (12.9% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the XTER:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for XTER:IX1

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€488.90
Price
€561.51
GF Value